NEW YORK, Jan. 23 - Galapagos Genomics and Exelixis have penned an agreement under which Exelixis will use Galapagos' adenoviral technology to analyze gene function in cell-based assays.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.
A BMJ study says that about half of former hematology-oncology regulators now work for industry.
Science should wish PhDs who leave academia well, a Nature editorial says.
New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.